Patents by Inventor Christoph Gleiter

Christoph Gleiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell selection method and cells obtained therefrom
    Patent number: 9701941
    Abstract: The present invention relates to a method for the in vitro selection of at least one therapeutic cell subpopulation from an original cell population of eukaryotic cells, as well as to the therapeutic cell subpopulation selected by the method, which can be used for the treatment of diseases of tissues or organs. The selected cells are highly migrative and the method according to the invention provides for the selection of these highly migrative subpopulations from a sample comprising a mixture of cells.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: July 11, 2017
    Assignee: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Lusine Danielyan, Christoph Gleiter, Matthias Schwab, Richard Schäfer
  • Use of the opposite cell differentiation program (OCDP) for the treatment of degenerated organs in the pathological state
    Patent number: 9157065
    Abstract: The present invention relates to a method for the treatment of organs which are degenerative and/or in the pathological state by means of the use of cells, which are phenotypically stably differentiating or differentiated but not necessarily ultimately predetermined with respect to development, from a donor organ selected according to the principles of the opposite cell differentiation program (OCDP) and also to the use of cells of this type for the treatment or for the production of a drug for treatment of the same. Furthermore, the present invention relates to pharmaceutical agents comprising suitable phenotypically stable cells, cells of a first organ which is different from the second organ with respect to organ type thereby being used, which, in the normal physiological state with respect to a predetermined set of expressed genes and/or phenotypical properties, have opposite properties to the second cells in the normal physiological state.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 13, 2015
    Assignee: Universitat Leipzig
    Inventors: Gayane Buniatian, Rolf Gebhardt, Christoph Gleiter, Lusine Danielyan, Barbara Proksch
  • Cell selection method and cells obtained therefrom
    Publication number: 20150166954
    Abstract: The present invention relates to a method for the in vitro selection of at least one therapeutic cell subpopulation from an original cell population of eukaryotic cells, as well as to the therapeutic cell subpopulation selected by the method, which can be used for the treatment of diseases of tissues or organs. The selected cells are highly migrative and the method according to the invention provides for the selection of these highly migrative subpopulations from a sample comprising a mixture of cells.
    Type: Application
    Filed: February 27, 2015
    Publication date: June 18, 2015
    Inventors: Lusine Danielyan, Christoph Gleiter, Matthias Schwab, Richard Schäfer
  • USE OF THE OPPOSITE CELL DIFFERENTIATION PROGRAM (OCDP) FOR THE TREATMENT OF DEGENERATED ORGANS IN THE PATHOLOGICAL STATE
    Publication number: 20100278786
    Abstract: The present invention relates to a method for the treatment of organs which are degenerative and/or in the pathological state by means of the use of cells, which are phenotypically stably differentiating or differentiated but not necessarily ultimately predetermined with respect to development, from a donor organ selected according to the principles of the opposite cell differentiation program (OCDP) and also to the use of cells of this type for the treatment or for the production of a drug for treatment of the same. Furthermore, the present invention relates to pharmaceutical agents comprising suitable phenotypically stable cells, cells of a first organ which is different from the second organ with respect to organ type thereby being used, which, in the normal physiological state with respect to a predetermined set of expressed genes and/or phenotypical properties, have opposite properties to the second cells in the normal physiological state.
    Type: Application
    Filed: April 18, 2008
    Publication date: November 4, 2010
    Applicant: Universitat Leipzig
    Inventors: Gayane Buniatian, Rolf Gebhardt, Christoph Gleiter, Lusine Danielyan, Barbara Proksch
  • Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
    Patent number: 7514072
    Abstract: The present invention relates to a method for the treatment of cerebral ischaemia and a drug for the treatment of cerebral ischaemia in particular in humans, as occurs for example in the case of stroke patients. It was found surprisingly that peripheral administering of erythropoietin to the cerebral tissue affected by the ischaemia has a distinctly protective effect. Erythropoietin has the effect thereby that the region of the cerebral tissue which is damaged permanently, in particular in the penumbra, is dramatically reduced relative to conventional measures in the case of cerebral ischaemia without erythropoietin administration.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: April 7, 2009
    Inventors: Hannelore Ehrenreich, Christoph Gleiter